Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Addus HomeCare Corp. (NASDAQ: ADUS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the information. Addus HomeCare is a Delaware corporation based in Frisco, Texas that provides personal care, hospice and home health services, and its filings offer detailed insight into this business.
Investors can use this page to access periodic and current reports where the company discusses its operations, financial condition and governance. Form 8-K filings, for example, are used by Addus HomeCare to report events such as quarterly earnings announcements, annual meeting voting results and acquisition-related updates. Recent 8-K and 8-K/A filings describe the company’s results of operations for specific quarters, the completion and financial reporting of the Gentiva personal care acquisition and the outcomes of its 2025 annual meeting of stockholders.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available through EDGAR) typically contain segment information for personal care, hospice and home health, along with discussions of payor mix, reimbursement exposure and risk factors. For a home health care services company like Addus HomeCare, these filings are central to understanding how government programs, managed care organizations and other payors affect revenue.
On Stock Titan, AI-generated summaries are designed to highlight key points from lengthy filings, such as changes in segment performance, updates on acquisitions, or governance decisions disclosed in proxy-related materials. Users can also review exhibits referenced in 8-K filings, including earnings press releases that are incorporated by reference. This page further facilitates monitoring of executive and director matters disclosed in meeting results and other governance-related filings.
By combining real-time EDGAR updates with AI explanations, the Addus HomeCare SEC filings page helps readers navigate complex regulatory documents, from 10-K and 10-Q reports to 8-K and 8-K/A filings, and understand how these disclosures relate to the company’s home-based care operations.
Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership in Addus HomeCare Corp. The firm reports beneficial ownership of 907,501 shares, representing 4.9% of the common stock class.
Wasatch Advisors has sole voting power over 619,613 shares and sole dispositive power over all 907,501 shares. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Addus HomeCare Corp.
Addus HomeCare Corp director Esteban Lopez reported selling a total of 150 shares of the company’s common stock on 12/15/2025. The Form 4 discloses two separate sales: 50 shares at a price of $114.55 and 100 shares at $115.50, each recorded as a disposition of common stock. After these transactions, Lopez beneficially owns 3,700 shares of Addus HomeCare common stock in direct ownership.
Addus HomeCare Corp executive Darby Anderson, EVP and Chief Government Relations Officer, reported an option exercise and share sale. On 11/19/2025, Anderson exercised 20,000 employee stock options at an exercise price of $22.70 per share, acquiring the same number of Addus HomeCare common shares. On the same date, Anderson sold 20,000 common shares at a price of $109 per share.
After these transactions, Anderson directly beneficially owned 44,144 shares of Addus HomeCare common stock, and held 0 remaining employee stock options. The filing notes that all options involved in this transaction were fully vested.
Addus HomeCare (ADUS) reported solid Q3 2025 growth, with net service revenues of $362.3 million, up from $289.8 million a year ago. Operating income rose to $32.9 million from $26.0 million, and net income increased to $22.8 million from $20.2 million. Diluted EPS was $1.24 versus $1.10.
Growth was broad-based: personal care delivered $275.8 million, hospice $68.9 million, and home health $17.6 million. For the first nine months, revenue reached $1.05 billion (from $857.5 million), with net income of $66.1 million (from $54.1 million) and diluted EPS of $3.60 (from $3.17). Cash from operations was $92.7 million.
Addus completed the Helping Hands acquisition on August 1 for approximately $21.4 million, adding $3.1 million of quarterly revenue and $0.4 million of operating income. The company continued to streamline its portfolio, progressing on the New York asset sale and recording $3.8 million in deferred payments year-to-date, with $2.3 million remaining as of September 30, 2025. Long-term revolver borrowings declined to $154.3 million from $223.0 million, and the company remained in compliance with credit covenants. Shares outstanding were 18,483,271 as of October 28, 2025.
Addus HomeCare Corporation furnished a Form 8-K announcing its results of operations for the fiscal quarter ended September 30, 2025. The company disclosed this through a press release attached as Exhibit 99.1, which is incorporated by reference.
The filing confirms the announcement date of November 3, 2025 and lists the company’s common stock trading as ADUS on The Nasdaq Stock Market. Detailed financial and operational results are presented in the attached press release.
Heather Brianne Dixon, a named officer of Addus HomeCare Corp (ADUS), reported an acquisition on 09/15/2025 of 28,370 shares of the issuer's common stock at a reported price of $0. Following the reported transaction, Ms. Dixon beneficially owns 32,189 shares, held directly. The filing includes an explanatory note that the newly reported shares vest in equal installments on September 15, 2026, September 15, 2027, and September 15, 2028, subject to customary continued-service provisions and acceleration on a change in control. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Addus HomeCare Corp (ADUS) Form 3: Heather Brianne Dixon, listed at 6303 Cowboys Way, Suite 600, Frisco, TX 75034, filed an initial Section 16 beneficial ownership statement reporting 3,819 shares of Common Stock held directly. The Form 3 is dated for the event on 09/15/2025 and was signed by an attorney-in-fact on 09/16/2025. Her relationship to the issuer is shown as an Officer (President and Chief Operating).
Addus HomeCare Corp. (ADUS) insider filing shows W. Bradley Bickham, the company's President and COO, reported a sale of 4,000 shares of common stock on 09/02/2025 at a weighted-average price of $115.75. After the sale he beneficially owned 37,605 shares. The Form 4 was filed as a single-person report and was signed by an attorney-in-fact for Mr. Bickham on 09/03/2025. The filing discloses the sale prices ranged from $115.48 to $116.14.
R. Dirk Allison, Chairman and CEO of Addus HomeCare (ADUS), reported multiple transactions on 09/02/2025. The filing shows acquisition of 25,000 shares via exercise of employee stock options at a $19.71 exercise price and two open-market disposals totaling 25,000 shares sold at weighted-average prices of $115.72 and $116.34. After these transactions the reporting person beneficially owned 166,461 shares directly. The filing notes all options are fully vested and provides weighted-average price ranges for the sales.
Addus HomeCare Corp. (ADUS) Form 144 shows a proposed sale of 4,000 common shares through Morgan Stanley Smith Barney on 09/02/2025 on NASDAQ, with an aggregate market value of $462,982.40 and 18,407,239 shares outstanding. The filing details that the shares were received as restricted stock in four grants between 03/02/2019 and 03/02/2022 totaling 4,000 shares. It also discloses a prior sale by the same person of 9,000 common shares on 08/13/2025 for gross proceeds of $1,038,105.91. The filer certifies no undisclosed material adverse information.